12 compound k purity (TargetMol)
TargetMol is a verified supplier 
TargetMol manufactures this product 
90
Structured Review
TargetMol
12 compound k purity
12 Compound K Purity, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+12/(20S)-Protopanaxadiol/pm41500477-425-77-76
Average 90 stars, based on 1 article reviews
12 Compound K Purity, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+12/(20S)-Protopanaxadiol/pm41500477-425-77-76
Average 90 stars, based on 1 article reviews
12 compound k purity - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: A natural protopanaxatriol from Panax notoginseng enhances osteosarcoma sensitivity to ferroptosis via ASCL4 upregulation Article Snippet: Current treatments for osteosarcoma, the most common primary bone cancer, including surgery, radiotherapy, and chemotherapy, are largely ineffective against metastatic and chemo-resistant cases, emphasizing the need for novel therapies.. In this study, we investigated (20S)-Protopanaxatriol [(20S)-PPT], a natural product from Panax notoginseng, an herb used both as food and medicine, for its ability to enhance osteosarcoma sensitivity to ferroptosis induced by inducers such as RSL3, ML210, and IKE.. Specifically, (20S)-PPT increased lipid peroxidation in osteosarcoma cells exposed to RSL3. Article Title: Ginsenoside Rh 3 enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. |
